ArticleAmerican health & drug benefits2017

Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes.

Kelvin Lingjet Tran et al.PubMed ↗Full text ↗

No numbers read from the abstract.